PTCT
Ptc Therapeutics
$67.37
−$0.20 (−0.3%)Sep 10, 2026
Key metrics
The numbers that frame PTCT today
- Market cap
- $5.62B
- P/E (TTM)
- -146.5
- EV / FCF
- -132.7
- Gross margin
- 93%
- EV / Sales
- 5.2
- ROIC
- 10.3%
- Div yield
- 0%
- 52wk Low
- $57.47
- 52wk High
- $90.86
Growth
Revenue and earnings trend for PTCT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PTCT
Is Ptc Therapeutics a good buy?
Hold. Ptc Therapeutics has mixed quality and mixed momentum. The setup is mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Ptc Therapeutics is selling at a high price.
What is the market capitalization of PTCT?
Ptc Therapeutics's market capitalization is $5.62B.
What is the P/E ratio for PTCT stock?
Ptc Therapeutics's current P/E ratio is -146.5.
What is the 52-week high for PTCT stock?
The 52-week high for Ptc Therapeutics is $90.86. The current close of $67.37 is 25.9% below that high.
What is the 52-week low for PTCT stock?
The 52-week low for Ptc Therapeutics is $57.47. The current close of $67.37 is 17.2% above that low.
Does PTCT stock pay dividends?
Ptc Therapeutics does not currently show a dividend per share in the company data.